nach oben

Lung

Erschienen in:

01.10.2011

Pulmonary Hypertension in a Stable Community-Based COPD Population

verfasst von: Vadim Fayngersh, Fotios Drakopanagiotakis, F. Dennis McCool, James R. Klinger

Erschienen in: Lung | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Study Objectives

The etiology and prevalence of pulmonary hypertension (PH) in patients with stable chronic obstructive pulmonary disease (COPD) is uncertain. This study was done to determine the prevalence of PH in stable COPD outpatients and to evaluate the relationship between PH and indices of pulmonary function.

Design

The study was a retrospective review of outpatients with COPD and PH defined as a history of cigarette smoking, pulmonary function tests (PFTs) that met GOLD criteria for airway obstruction, an echocardiogram within 6 months of PFTs, and a left ventricular ejection fraction (LVEF) >55%. Of the 159 individuals who met all inclusion criteria, 105 had a sufficient tricuspid regurgitant jet to measure systolic pulmonary artery pressure (sPAP). PH was defined as sPAP ≥36 mmHg.

Measurements and Results

The prevalence of PH was 60% (63/105) in the study group. The mean sPAP in patients with PH was 45 ± 6 mmHg. COPD patients with PH were older (71.1 ± 11.8 vs. 63.7 ± 10.2 years, P = 0.001), had lower FEV₁% predicted (51.8 ± 18.8 vs. 62.7 ± 20.5%, P = 0.006), a higher RV/TLC (0.55 ± 0.10 vs. 0.48 ± 0.11, P = 0.001), and a lower % predicted DL_CO (59.6 ± 19.5% vs. 71.9 ± 24.9%, P = 0.006). Only age (P < 0.002) and prebronchodilator FEV₁% predicted (P < 0.006) predicted PH by logistic regression analysis. No differences were observed in gender, BMI, smoking status, pack years, total lung capacity (TLC), or residual volume (RV).

Conclusion

PH is common in COPD. Older individuals and those with more airway obstruction are at greater risk for developing PH.

Mannino DM, Braman S (2007) The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4:502–506PubMedCrossRef

Jemal A, Ward E, Hao Y, Thun M (2005) Trends in the leading causes of death in the United States, 1970–2002. JAMA 294(10):1255–1259PubMedCrossRef

Weitzenblum E, Sautegeau A, Ehrhart M et al (1984) Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 130:993–998PubMed

Weitzenblum E, Hirth C, Ducolone A et al (1981) Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 36:752–758PubMedCrossRef

Oswald-Mammosser M, Weitzenblum E, Quoix E et al (1995) Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 107:1193–1198PubMedCrossRef

Wuertemberger G, Zielinsky J, Sliwinsky P et al (1990) Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy. Lung 168:S762–S769CrossRef

Kessler R, Faller M, Fourgaut G et al (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:158–164PubMed

Higham MA, Dawson D, Joshi J et al (2001) Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J 17:350–355PubMedCrossRef

Higenbottam T (2005) Pulmonary hypertension and chronic obstructive pulmonary disease: a case for treatment. Proc Am Thorac Soc 2:12–19PubMedCrossRef

10.

Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef

11.

Badesch DB, Champion HC, Sanchez et al (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54:S55–S66PubMedCrossRef

12.

Falk JA, Kadiev S, Criner GJ et al (2008) Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:543–548PubMedCrossRef

13.

Matheson MC, Raven J, Johns DP et al (2007) Associations between reduced diffusing capacity and airflow obstruction in community-based subjects. Respir Med 101:1730–1737PubMedCrossRef

14.

Thabut G, Dauriat G, Stern JB et al (2005) Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127:1531–1536PubMedCrossRef

15.

Scharf SM, Iqbal M, Keller C et al (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166:314–322PubMedCrossRef

16.

Kessler R, Faller M, Weitzenblum E et al (2001) “Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 164:219–224PubMed

17.

Lam CS, Borlaug BA, Kane GC, Enders FT, Rodeheffer RJ, Redfield MM (2009) Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 119(20):2663–2670PubMedCrossRef

18.

Dallari R, Barozzi G, Pinelli G et al (1994) Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Respiration 61(1):8–13PubMedCrossRef

19.

McGhan R, Radcliff T, Fish R et al (2007) Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132:1748–1755PubMedCrossRef

20.

Oswald-Mammosser M, Apprill M, Bachez P et al (1991) Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration 58:304–310PubMedCrossRef

21.

Williams IP, Boyd MJ, Humberstone AM et al (1984) Pulmonary arterial hypertension and emphysema. Br J Dis Chest 78:211–216PubMedCrossRef

22.

Chaouat A, Bugnet AS, Kadaoui N et al (2005) Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172:189–194PubMedCrossRef

23.

Chaouat A, Savale L, Chouaid C et al (2009) Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 136(3):678–687PubMedCrossRef

24.

Sun XG, Hansen JE, Oudiz RJ et al (2003) Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 41:1028–1035PubMedCrossRef

25.

Bishop JM, Csukas M (1989) Combined use of non-invasive techniques to predict pulmonary arterial pressure in chronic respiratory disease. Thorax 44:85–96PubMedCrossRef

26.

Sims MW, Margolis DJ, Localio AR et al (2009) Impact of pulmonary artery pressure on exercise function in severe COPD. Chest 136:412–419PubMedCrossRef

27.

Butler J, Schrijen F, Henriquez A et al (1988) Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis 138:350–354PubMed

28.

Sciurba FC, Rogers RM, Keenan RJ et al (1996) Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 334:1095–1099PubMedCrossRef

29.

Criner GJ, Scharf SM, Falk JA, National Emphysema Treatment Trial Research Group et al (2007) Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med 176(3):253–260PubMedCrossRef

30.

Wright JL, Petty T, Thurlbeck WM (1992) Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung 170:109–124PubMedCrossRef

31.

Naeije R, Barbera JA (2001) Pulmonary hypertension associated with COPD. Crit Care 5:286–289PubMedCrossRef

32.

Wilkinson M, Langhorne CA, Heath D et al (1988) A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med 66:65–85PubMed

33.

Peinado VI, Barbera JA, Abate P et al (1999) Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1605–1611PubMed

34.

Timms RM, Khaja FU, Williams GW (1985) Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 102:29–36PubMed

35.

Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 93:391–398

36.

Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ (2008) Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):549–555PubMedCrossRef

37.

Berger M, Haimowitz A, Van Tosh A et al (1985) Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 6:359–365PubMedCrossRef

38.

Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70:657–662PubMedCrossRef

39.

Arcasoy SM, Christie JD, Ferrari VA et al (2003) Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 167:735–740PubMedCrossRef

40.

Laaban JP, Diebold B, Zelinski R et al (1989) Noninvasive estimation of systolic pulmonary artery pressure using Doppler echocardiography in patients with chronic obstructive pulmonary disease. Chest 96:1258–1262PubMedCrossRef

41.

Tramarin R, Torbicki A, Marchandise B et al (1991) Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. Eur Heart J 12:103–111PubMed

42.

Bach DS, Curtis JL, Christensen PJ et al (1998) Preoperative echocardiographic evaluation of patients referred for lung volume reduction surgery. Chest 114:972–980PubMedCrossRef

43.

Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M (2008) A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 32(3):619–628PubMedCrossRef

44.

Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barberà JA (2010) Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 181(3):270–278PubMedCrossRef

45.

Rao RS, Singh S, Sharma BB, Agarwal VV, Singh V (2011) Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. Indian J Chest Dis Allied Sci 53(2):81–85PubMed

Titel: Pulmonary Hypertension in a Stable Community-Based COPD Population
verfasst von: Vadim Fayngersh
Fotios Drakopanagiotakis
F. Dennis McCool
James R. Klinger
Publikationsdatum: 01.10.2011
Verlag: Springer-Verlag
Erschienen in: Lung / Ausgabe 5/2011
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-011-9315-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Study Objectives

Design

Measurements and Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2011

Comparison Between Cardiopulmonary Exercise Testing Parameters and Computed Tomography Findings in Patients with Thoracic Sarcoidosis

Value of Impedance Cardiography in Patients Studied for Pulmonary Hypertension

Involvement of IL-10 Gene Promoter Polymorphisms in the Susceptibility for Childhood Asthma

Improved Outcomes of Patients with End-stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure

Adhesion Molecules Affected by Treatment of Lung Cancer Cells with Epidermal Growth Factor